Human Genome Project

Photo credit: Smithsonian This month ’€œGenome: Unlocking Life’s Code,’€ first state-of-the-art exhibition about genome science, opened at the Museum of Natural History in partnership with the National Human Genome Research Institute (NHGRI) . The exhibit boasts cutting-edge interactives, 3D models, custom animations and engaging videos of real-life stories. According to Dr. Eric D. Green, director of the National Human Genome Research Institute (NHGRI), one of the 27 institutes and centers that make up the National Institutes of Health (NIH), “This exhibition reflects a remarkably productive collaboration between components of two scientific icons of the U.S. government – the Smithsonian...
Dear Research Advocate: According to our new national public opinion poll on clinical trials and related topics, most Americans are willing to share their personal health data to advance research, and 72% would be willing to participate in a clinical trial if recommended by their doctor. This complements what we know from other polling, i.e. that Americans want research to proceed at a pace of scientific opportunity. Yet we continue to lose ground in the gridlocked political environment, which, by its inaction, is dashing the hopes of patients and families anxious for new therapies and cures. What’€™s wrong with this picture? It isn’€™t as though research hasn’€™t yielded both societal and...
Large medical centers across the U.S. are investing in a burgeoning area of healthcare for their cancer patients: €œprecision medicine. Substantial investments are being made to not only build new laboratory facilities and purchase research equipment, but also to staff these new facilities. Universities like Weill Cornell Medical College , Harvard Medical School , and Johns Hopkins University are joining clinical centers like Memorial Sloan-Kettering Cancer Center in building an infrastructure for personalized medicine with the hope of playing a bigger role in the development of new drugs. This approach is building off of years of federal investment in genomics research. First, the Human...
Dear Research Advocate, Setting a breathtaking goal for Congress and the nation, the president called for returning our nation to levels of R&D investment not seen since the height of the space race in his State of the Union address Tuesday evening. He spoke of the potential to defeat Alzheimer’€™s and to assure an ’€œAIDS-free generation’€; and he used the human genome project to illustrate the economic as well as human return on taxpayer investment in research. We were thrilled that the president listed medical research among the nation’€™s top priorities ’€“ along with defense, education and energy ’€“ right at the beginning of his speech, when he described the devastating damage...
Dear Research Advocate, As the political conventions get underway, we have further evidence that voters want candidates to make research for health a prominent issue, now and after the election. Our latest national public opinion poll, conducted a week ago, shows voters want to elect candidates who value and highly prioritize the importance of medical progress. Among the highlights: 90% say it’€™s important for candidates to address medical research; 59% say elected officials in Washington are not paying enough attention to combating deadly diseases, so much so that 63% say the next president should announce initiatives promoting medical progress in his ’€œfirst 100 days in office.’€ And...

Sidebar Quote

You can change the image of things to come. But you can’t do it sitting on your hands … The science community should reach out to Congress and build bridges.
The Honorable John E. Porter